Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)

Recruiting now · Not applicable

Conditions studied: Glioblastoma (GBM)

In brief

The Brain Cancer Program, in partnership with the Center for Music and Medicine at Johns Hopkins, will study whether music therapy is feasible in newly diagnosed GBM patients undergoing standard care.

Key facts

Study ID

NCT07375992

Run by

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

People needed

35

Starts

2026-05-26

Expected to finish

2029-02-28

Last updated by the study team

2026-06-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Glioblastoma (Newly Diagnosed)
• Cognitive capacity to respond to surveys
• Access to computer and web access
• Ability to attend virtual music therapy sessions
• Audibly process music
• Proficient in English

You may not qualify if…

• Not planning to undergo standard of care radiation therapy and concurrent and adjuvant temozolomide.
• A life expectancy of less than 6 months.
• Concurrent use of any other standard or investigational agents (excepting tumor treating fields).
• Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection or psychiatric illness/social situations that would limit adherence with study requirements.

Where it is running

• Oncology- Broadway — Baltimore, Maryland, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.